scispace - formally typeset
Search or ask a question
Institution

University of Texas System

EducationAustin, Texas, United States
About: University of Texas System is a education organization based out in Austin, Texas, United States. It is known for research contribution in the topics: Cancer & Population. The organization has 13901 authors who have published 10925 publications receiving 319328 citations. The organization is also known as: UT System.
Topics: Cancer, Population, Antigen, Gene, Antibody


Papers
More filters
Journal ArticleDOI
TL;DR: In this paper, the authors measured the relative changes in acute and late response when the dose fractionation pattern of a 6.5 week treatment was changed from five times to twice weekly.
Abstract: Areas of pigs' skin were exposed to fractionated doses of ..gamma.. rays, and their acute and late (several months) responses were measured as desquamation and degree of contraction, respectively. The purpose was to measure the relative changes in acute and late response when the dose fractionation pattern of a 6.5 week treatment was changed from five times to twice weekly. It was found that NSD formula did not predict isoeffect for reduced numbers of dose-fractions. Moreover, early skin response did not predict the magnitude of late damage when dose-fractionation was altered from conventional daily routines. Specifically, 200 rad five times weekly was equivalent, for acute response, to a dose greater than 435 rad twice weekly (p<0.01), whereas, for late response, equivalence was achieved at a dose less than 360 rad twice weekly (p<0.0526).

79 citations

Proceedings ArticleDOI
01 Jan 1992

78 citations

Patent
20 Sep 1990
TL;DR: An active peptide consisting essentially of 7 to about 30 residence and having a sequence that corresponds to a conserved domain of an HIV protein is disclosed, as is a multimer containing that peptide, an aqueous composition containing the multimer and methods of using and making the same.
Abstract: An active peptide consisting essentially of 7 to about 30 residence and having a sequence that corresponds to a conserved domain of an HIV protein is disclosed, as is a multimer containing that peptide, an aqueous composition containing the multimer and methods of using and making the same. The aqueous composition containing an immunologically effective amount of an active peptide multimer, when introduced into an immunocompetent host animal in an immunologically effective amount, is capable of inducing cellular immunity against the native HIV protein to which the active peptide of the multimer corresponds in sequence, but is not capable of inducing production of antibodies that immunoreact with that native HIV protein.

78 citations

Journal ArticleDOI
TL;DR: Results presented here indicate that, upon reaching plateau phase, normal cell populations stop in early G1, while most cells in transformed cell lines (CHO, HeLa, and mouse SV‐3T3) accumulate in late G1.
Abstract: The object of this study was to develop a map of G1 phase on the basis of the progressive changes taking place in the morphology of the prematurely condensed chromosomes as the cells traverse through G1 and then use this technique to determine the cell cycle location of normal and transformed cell populations in plateau phase. The morphology of the prematurely condensed chromosomes (PCC) of G1 cells in random populations was found to be highly variable. For a better understanding of the relationship between the morphology of the G1-PCC and their position within G1 phase, synchronized populations of Chinese hamster ovary (CHO) cells in early, mid-, and late G1 phase were fused with mitotic cells. Early G1 cells resulted in highly condensed G1-PCC, while late G1 cells gave very extended G1-PCC. Mid-G1 cells resulted in PCC of intermediate condensation. To test the validity of these criteria for mapping the position of a cell in the cell cycle, synchronous G1 cell populations were treated with a variety of metabolic inhibitors. Cycloheximide and actinomycin D were shown to block cell in early G1 phase, while excess thymidine and hydroxyurea blocked cells in early S phase. The results presented here indicate that, upon reaching plateau phase, normal cell populations (BALB-C mouse 3T3, human PA-2, and WI 38) stop in early G1, while most cells in transformed cell lines (CHO, HeLa, and mouse SV-3T3) accumulate in late G1.

78 citations


Authors

Showing all 13902 results

NameH-indexPapersCitations
Yi Chen2174342293080
Joseph L. Goldstein207556149527
Eric N. Olson206814144586
Hagop M. Kantarjian2043708210208
Thomas C. Südhof191653118007
Gordon B. Mills1871273186451
Michael S. Brown185422123723
Eric Boerwinkle1831321170971
Russel J. Reiter1691646121010
John D. Minna169951106363
Timothy A. Springer167669122421
Gabriel N. Hortobagyi1661374104845
Rodney S. Ruoff164666194902
Ralph A. DeFronzo160759132993
Ronald A. DePinho160486104039
Network Information
Related Institutions (5)
Memorial Sloan Kettering Cancer Center
65.3K papers, 4.4M citations

87% related

National Institutes of Health
297.8K papers, 21.3M citations

87% related

University of Texas Southwestern Medical Center
75.2K papers, 4.4M citations

87% related

University of Pittsburgh
201K papers, 9.6M citations

87% related

University of Texas MD Anderson Cancer Center
92.5K papers, 4.7M citations

87% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20222
2021123
2020197
2019239
2018248
2017290